Approval · Notice of Compliance 20591 · 2018
ICLUSIG: Notice of Compliance 20591
Issued March 8, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20591
- Date
- March 8, 2018
- Company
- Ariad Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To introduce a carton label and update manufacturer contact information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ICLUSIG | Not yet assigned | — |
Medicinal ingredients
- PONATINIB HYDROCHLORIDE 15 MG per TAB
- PONATINIB HYDROCHLORIDE 45 MG per TAB